Effect of renin-angiotensin system inhibitors in elderly patients with heart failure and reduced ejection fraction

2 September 2024 (09:00 - 09:50)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Yodo Tamaki

Tenri Hospital, Tenri (Japan)

7 More presentations in this session

Presentation thumbnail

Spectrum of heart failure in 16 sub-saharan countries: drugs strategies and 8-year trends (the february study 2016-2023)

Professor I. Diop (Dakar, SN)

Abstract Slides Video

Presentation thumbnail

Combination of diuretics to overcome diuretic resistance in acute heart failure: systematic review and updated network meta-analysis

Doctor I. Girard Cunha Vieira Lima (Sao Paulo, BR)

Abstract Slides Video

Presentation thumbnail

REDUCE-HF: a stronger heart go a long way

Doctor K. Kam (Shatin, HK)

Abstract Slides Video

Presentation thumbnail

Comparing treatment strategies for heart failure: a real-world analysis of adding ARNI or SGLT2i to older GDMT

Doctor P. Amornritvanich (Bangkok, TH)

Abstract Slides Video

Presentation thumbnail

Rationale and study design of the international randomized control trial MYocarditis THerapy with Steroids: the MYTHS trial

Doctor E. Ammirati (Milan, IT)

Abstract Slides Video

Access the full session

Session thumbnail

New insights into pharmacotherapy for acute heart failure

The Event

Event poster

ESC Congress 2024

2 September 2024 09:00 CET

You may be interested in

Congress Presentation

Comparative analysis of renin-angiotensin system inhibitors/angiotensin receptor neprilysin inhibitor and mineralocorticoid receptor antagonists in heart failure with mildly reduced ejection fraction

Congress Presentation

Evidence-based therapy in older patients with heart failure with reduced ejection fraction, is the age truly important?

Congress Session

Pharmacotherapy

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources